Candriam Equities L Oncology Impact, N - Capitalisation
LU2346866317
Candriam Equities L Oncology Impact, N - Capitalisation/ LU2346866317 /
NAV 10.06.2024
Diff.+1,0100
Ertragstyp
Ausrichtung
Fondsgesellschaft
159,3800 EUR
+0,64%
thesaurierend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in EUR
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.397,3999
+7,95%
+1,59%
Candriam Equities L Oncology Imp...
thesaurierend
2.561,9700
+8,09%
+1,97%
Candriam Equities L Oncology Imp...
thesaurierend
207,2800
+4,43%
-8,91%
Candriam Equities L Oncology Imp...
thesaurierend
2.240,0901
+5,85%
+11,92%
Candriam Equities L Oncology Imp...
ausschüttend
1.608,6000
+7,61%
+0,61%
Candriam Equities L Oncology Imp...
thesaurierend
247,9700
+6,73%
+10,91%
Candriam Equities L Oncology Imp...
ausschüttend
235,7400
+6,60%
-2,17%
Candriam Equities L Oncology Imp...
ausschüttend
190,9900
+7,51%
+0,32%
Candriam Equities L Oncology Imp...
ausschüttend
20.703,0000
+3,07%
-2,20%
Candriam Equities L Oncology Imp...
thesaurierend
158,4700
+5,73%
+11,54%
Candriam Equities L Oncology Imp...
thesaurierend
2.108,6599
+5,41%
-6,30%
Candriam Equities L Oncology Imp...
thesaurierend
262,8800
+7,63%
+13,75%
Candriam Equities L Oncology Imp...
thesaurierend
206,7100
+4,01%
-9,99%
Candriam Equities L Oncology Imp...
thesaurierend
286,3900
+7,50%
+0,31%
Candriam Equities L Oncology Imp...
thesaurierend
193,6600
+5,30%
-
Candriam Equities L Oncology Imp...
thesaurierend
1.848,0400
+6,19%
-
Candriam Equities L Oncology Imp...
thesaurierend
2.881,3601
+8,28%
+3,83%
Candriam Equities L Oncology Imp...
thesaurierend
159,3800
-
-
Candriam Equities L Oncology Imp...
thesaurierend
274,1100
+7,27%
+0,94%
Performance
lfd. Jahr
-
6 Monate
-
1 Jahr
-
3 Jahre
-
5 Jahre
-
10 Jahre
-
seit Beginn
+4,48%
Jahr